WillScot Announces 2025 Investor Day & Reaffirms FY2024 Outlook
Notified -
Globe Newswire9-01-2025, 20:00
Junshi Biosciences Announces Phase 3 Study of Toripalimab Combined with Bevacizumab for the First-line Treatment of Advanced Hepatocellular Carcinoma Meets Primary Endpoint 12-06-2024, 09:06